Free Trial

Voloridge Investment Management LLC Makes New Investment in Option Care Health, Inc. (NASDAQ:OPCH)

Option Care Health logo with Medical background

Voloridge Investment Management LLC bought a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 1,182,225 shares of the company's stock, valued at approximately $27,428,000. Voloridge Investment Management LLC owned approximately 0.69% of Option Care Health at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in OPCH. Murphy & Mullick Capital Management Corp purchased a new position in Option Care Health in the 4th quarter valued at about $26,000. UMB Bank n.a. raised its holdings in shares of Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after acquiring an additional 346 shares during the last quarter. Signaturefd LLC lifted its holdings in Option Care Health by 487.9% in the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company's stock valued at $28,000 after purchasing an additional 1,005 shares in the last quarter. Quadrant Capital Group LLC boosted its stake in Option Care Health by 172.8% during the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock worth $40,000 after purchasing an additional 1,099 shares during the last quarter. Finally, Johnson Financial Group Inc. purchased a new stake in shares of Option Care Health during the fourth quarter worth $47,000. Institutional investors and hedge funds own 98.05% of the company's stock.

Option Care Health Trading Up 1.9%

Option Care Health stock traded up $0.61 during mid-day trading on Tuesday, hitting $32.02. The company's stock had a trading volume of 186,832 shares, compared to its average volume of 1,856,322. The stock's fifty day moving average is $32.93 and its two-hundred day moving average is $29.45. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The firm has a market capitalization of $5.24 billion, a PE ratio of 26.89, a price-to-earnings-growth ratio of 2.30 and a beta of 0.76. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.04. The firm had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.26 billion. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. Option Care Health's revenue was up 16.3% on a year-over-year basis. During the same period in the previous year, the firm earned $0.26 EPS. On average, analysts anticipate that Option Care Health, Inc. will post 1.22 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. Barrington Research restated an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a research report on Wednesday, April 30th. JMP Securities restated a "market outperform" rating and set a $36.00 target price on shares of Option Care Health in a report on Tuesday, April 22nd. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and increased their price target for the company from $38.00 to $40.00 in a report on Wednesday, April 30th. Finally, JPMorgan Chase & Co. lifted their price target on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat, Option Care Health has a consensus rating of "Moderate Buy" and an average target price of $35.50.

Get Our Latest Stock Analysis on Option Care Health

Insider Buying and Selling

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares in the company, valued at $1,495,835.24. This represents a 40.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.64% of the stock is currently owned by corporate insiders.

Option Care Health Profile

(Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Recommended Stories

Institutional Ownership by Quarter for Option Care Health (NASDAQ:OPCH)

Should You Invest $1,000 in Option Care Health Right Now?

Before you consider Option Care Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.

While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines